160 related articles for article (PubMed ID: 32143177)
1. Temozolomide and Pazopanib Combined with FOLFOX Regressed a Primary Colorectal Cancer in a Patient-derived Orthotopic Xenograft Mouse Model.
Zhu G; Zhao M; Han Q; Tan Y; Sun Y; Bouvet M; Clary B; Singh SR; Ye J; Hoffman RM
Transl Oncol; 2020 Mar; 13(3):100739. PubMed ID: 32143177
[TBL] [Abstract][Full Text] [Related]
2. Pazopanib Inhibits Tumor Growth, Lymph-node Metastasis and Lymphangiogenesis of an Orthotopic Mouse of Colorectal Cancer.
Zhu G; Zhao M; Han Q; Tan Y; Sun YU; Bouvet M; Singh SR; Ye J; Hoffman RM
Cancer Genomics Proteomics; 2020; 17(2):131-139. PubMed ID: 32108035
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin-resistant pleomorphic liposarcoma with PDGFRA gene amplification is targeted and regressed by pazopanib in a patient-derived orthotopic xenograft mouse model.
Kiyuna T; Murakami T; Tome Y; Igarashi K; Kawaguchi K; Miyake K; Miyake M; Li Y; Nelson SD; Dry SM; Singh AS; Russell TA; Singh SR; Kanaya F; Eilber FC; Hoffman RM
Tissue Cell; 2018 Aug; 53():30-36. PubMed ID: 30060824
[TBL] [Abstract][Full Text] [Related]
4. Combination of Trabectedin With Irinotecan, Leucovorin and 5-Fluorouracil Arrests Primary Colorectal Cancer in an Imageable Patient-derived Orthotopic Xenograft Mouse Model.
Zhu G; Zhao M; Han Q; Tan Y; Sun YU; Bouvet M; Clary B; Singh SR; Ye J; Hoffman RM
Anticancer Res; 2019 Dec; 39(12):6463-6470. PubMed ID: 31810910
[TBL] [Abstract][Full Text] [Related]
5. Combination of Trabectedin With Oxaliplatinum and 5-Fluorouracil Arrests a Primary Colorectal Cancer in a Patient-derived Orthotopic Xenograft Mouse Model.
Zhu G; Zhao M; Han Q; Tan Y; Sun YU; Bouvet M; Singh SR; Ye J; Hoffman RM
Anticancer Res; 2019 Nov; 39(11):5999-6005. PubMed ID: 31704825
[TBL] [Abstract][Full Text] [Related]
6. High Efficacy of Pazopanib on an Undifferentiated Spindle-Cell Sarcoma Resistant to First-Line Therapy Is Identified With a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.
Igarashi K; Kawaguchi K; Murakami T; Kiyuna T; Miyake K; Singh AS; Nelson SD; Dry SM; Li Y; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Eilber FC; Hoffman RM
J Cell Biochem; 2017 Sep; 118(9):2739-2743. PubMed ID: 28176365
[TBL] [Abstract][Full Text] [Related]
7. Pazopanib regresses a doxorubicin-resistant synovial sarcoma in a patient-derived orthotopic xenograft mouse model.
Igarashi K; Kawaguchi K; Kiyuna T; Miyake K; Miyake M; Nelson SD; Russell TA; Dry SM; Li Y; Yamamoto N; Hayashi K; Kimura H; Miwa S; Higuchi T; Singh SR; Tsuchiya H; Hoffman RM
Tissue Cell; 2019 Jun; 58():107-111. PubMed ID: 31133237
[TBL] [Abstract][Full Text] [Related]
8. Temozolomide targets and arrests a doxorubicin-resistant follicular dendritic-cell sarcoma patient-derived orthotopic xenograft mouse model.
Oshiro H; Tome Y; Kiyuna T; Miyake K; Kawaguchi K; Higuchi T; Miyake M; Zang Z; Razmjooei S; Barangi M; Wangsiricharoen S; Nelson SD; Li Y; Bouvet M; Singh SR; Kanaya F; Hoffman RM
Tissue Cell; 2019 Jun; 58():17-23. PubMed ID: 31133242
[TBL] [Abstract][Full Text] [Related]
9. Combination of gemcitabine and docetaxel regresses both gastric leiomyosarcoma proliferation and invasion in an imageable patient-derived orthotopic xenograft (iPDOX) model.
Kawaguchi K; Igarashi K; Murakami T; Kiyuna T; Nelson SD; Dry SM; Li Y; Russell TA; Singh AS; Chmielowski B; Unno M; Eilber FC; Hoffman RM
Cell Cycle; 2017 Jun; 16(11):1063-1069. PubMed ID: 28426279
[TBL] [Abstract][Full Text] [Related]
10. A combination of irinotecan/cisplatinum and irinotecan/temozolomide or tumor-targeting Salmonella typhimurium A1-R arrest doxorubicin- and temozolomide-resistant myxofibrosarcoma in a PDOX mouse model.
Kiyuna T; Tome Y; Murakami T; Miyake K; Igarashi K; Kawaguchi K; Oshiro H; Higuchi T; Miyake M; Sugisawa N; Zhang Z; Razmjooei S; Wangsiricharoen S; Chmielowski B; Nelson SD; Russell TA; Dry SM; Li Y; Eckardt MA; Singh AS; Chawla S; Kanaya F; Eilber FC; Singh SR; Zhao M; Hoffman RM
Biochem Biophys Res Commun; 2018 Nov; 505(3):733-739. PubMed ID: 30292411
[TBL] [Abstract][Full Text] [Related]
11. Eribulin Regresses a Doxorubicin-resistant Dedifferentiated Liposarcoma in a Patient-derived Orthotopic Xenograft Mouse Model.
Igarashi K; Kawaguchi K; Kiyuna T; Miyake K; Higuchi T; Yamamoto N; Hayashi K; Kimura H; Miwa S; Singh SR; Tsuchiya H; Hoffman RM
Cancer Genomics Proteomics; 2020; 17(4):351-358. PubMed ID: 32576580
[TBL] [Abstract][Full Text] [Related]
12. Temozolomide regresses a doxorubicin-resistant undifferentiated spindle-cell sarcoma patient-derived orthotopic xenograft (PDOX): precision-oncology nude-mouse model matching the patient with effective therapy.
Igarashi K; Kawaguchi K; Kiyuna T; Miyake K; Miyake M; Li Y; Nelson SD; Dry SM; Singh AS; Elliott IA; Russell TA; Eckardt MA; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Eilber FC; Hoffman RM
J Cell Biochem; 2018 Aug; 119(8):6598-6603. PubMed ID: 29737543
[TBL] [Abstract][Full Text] [Related]
13. Patterns of sensitivity to a panel of drugs are highly individualised for undifferentiated/unclassified soft tissue sarcoma (USTS) in patient-derived orthotopic xenograft (PDOX) nude-mouse models.
Kawaguchi K; Igarashi K; Miyake K; Kiyuna T; Miyake M; Singh AS; Chmielowski B; Nelson SD; Russell TA; Dry SM; Li Y; Unno M; Singh SR; Eilber FC; Hoffman RM
J Drug Target; 2019 Feb; 27(2):211-216. PubMed ID: 30024282
[TBL] [Abstract][Full Text] [Related]
14. Temozolomide combined with irinotecan regresses a cisplatinum-resistant relapsed osteosarcoma in a patient-derived orthotopic xenograft (PDOX) precision-oncology mouse model.
Igarashi K; Kawaguchi K; Kiyuna T; Miyake K; Miyake M; Li Y; Nelson SD; Dry SM; Singh AS; Elliott IA; Russell TA; Eckardt MA; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Eilber FC; Hoffman RM
Oncotarget; 2018 Jan; 9(8):7774-7781. PubMed ID: 29487690
[TBL] [Abstract][Full Text] [Related]
15. Salmonella typhimurium A1-R targeting of a chemotherapy-resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib or temozolomide.
Kawaguchi K; Igarashi K; Murakami T; Kiyuna T; Zhao M; Zhang Y; Nelson SD; Russell TA; Dry SM; Singh AS; Chmielowski B; Li Y; Unno M; Eilber FC; Hoffman RM
Cell Cycle; 2017 Jul; 16(13):1288-1294. PubMed ID: 28622068
[TBL] [Abstract][Full Text] [Related]
16. Tumor-targeting Salmonella typhimurium A1-R combined with temozolomide regresses malignant melanoma with a BRAF-V600E mutation in a patient-derived orthotopic xenograft (PDOX) model.
Kawaguchi K; Igarashi K; Murakami T; Chmielowski B; Kiyuna T; Zhao M; Zhang Y; Singh A; Unno M; Nelson SD; Russell TA; Dry SM; Li Y; Eilber FC; Hoffman RM
Oncotarget; 2016 Dec; 7(52):85929-85936. PubMed ID: 27835903
[TBL] [Abstract][Full Text] [Related]
17. Temozolomide combined with irinotecan caused regression in an adult pleomorphic rhabdomyosarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model.
Igarashi K; Kawaguchi K; Kiyuna T; Murakami T; Miwa S; Nelson SD; Dry SM; Li Y; Singh AS; Kimura H; Hayashi K; Yamamoto N; Tsuchiya H; Eilber FC; Hoffman RM
Oncotarget; 2017 Sep; 8(44):75874-75880. PubMed ID: 29100276
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal Metastases in a Patient-derived Orthotopic Xenograft (PDOX) Model of Colon Cancer Imaged Non-invasively
Park JH; Zhao M; Oshiro H; Miyake K; Higuchi T; Reynoso J; Razmjooei S; Bouvet M; Clary B; Zhang Z; Sugisawa N; Yamamoto J; Singh SR; Hoffman RM
Anticancer Res; 2019 Jul; 39(7):3463-3467. PubMed ID: 31262870
[TBL] [Abstract][Full Text] [Related]
19. A patient-derived orthotopic xenograft (PDOX) nude-mouse model precisely identifies effective and ineffective therapies for recurrent leiomyosarcoma.
Zhang Z; Hu K; Kiyuna T; Miyake K; Kawaguchi K; Igarashi K; Nelson SD; Li Y; Singh SR; Hoffman RM
Pharmacol Res; 2019 Apr; 142():169-175. PubMed ID: 30807865
[TBL] [Abstract][Full Text] [Related]
20. Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model.
Kawaguchi K; Igarashi K; Li S; Han Q; Tan Y; Kiyuna T; Miyake K; Murakami T; Chmielowski B; Nelson SD; Russell TA; Dry SM; Li Y; Unno M; Eilber FC; Hoffman RM
Oncotarget; 2017 Oct; 8(49):85516-85525. PubMed ID: 29156737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
